Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
Version 2 2024-06-05, 12:39Version 2 2024-06-05, 12:39
Version 1 2020-01-01, 00:00Version 1 2020-01-01, 00:00
journal contribution
posted on 2024-06-05, 12:39authored byJ Furler, D O'Neal, Jane SpeightJane Speight, I Blackberry, JA Manski-Nankervis, S Thuraisingam, K de La Rue, L Ginnivan, R Doyle, Elizabeth Holmes-TruscottElizabeth Holmes-Truscott, K Khunti, K Dalziel, J Chiang, R Audehm, M Kennedy, M Clark, A Jenkins, AJ Lake, AS Januszewski, M Catchpool, D Liew, P Clarke, J Best
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial